Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Anaplastic large cell lymphoma T- and null-cell types
ADR ID BADD_A06896
ADR Hierarchy
01      Blood and lymphatic system disorders
01.11      Lymphomas non-Hodgkin's T-cell
01.11.02      Anaplastic large cell lymphomas T- and null-cell types
01.11.02.002      Anaplastic large cell lymphoma T- and null-cell types
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.17      Lymphomas non-Hodgkin's T-cell
16.17.02      Anaplastic large cell lymphomas T- and null-cell types
16.17.02.002      Anaplastic large cell lymphoma T- and null-cell types
Description Not Available
MedDRA Code 10002227
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Anaplastic large cell lymphoma T- and null-cell types | Anaplastic large cell lymphoma T- and null-cell types NOS | Large cell immunoblastic lymphoma (Anaplastic large cell lymphoma T- and null-cell types) | T-immunoblastic sarcoma (Anaplastic large cell lymphoma T- and null-cell types) | T-large cell anaplastic (Ki-1+) lymphoma (Kiel Classification) | Anaplastic large-cell lymphoma, primary cutaneous type | Anaplastic large-cell lymphoma, primary systemic type
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00277Bisoprolol0.001342%
BADD_D01253Lenalidomide0.001737%
BADD_D02464Fingolimod0.001737%
The 1th Page    1    Total 1 Pages